Investigational Drug Information for SRX246
✉ Email this page to a colleague
What is the development status for investigational drug SRX246?
SRX246 is an investigational drug.
There have been 8 clinical trials for SRX246.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2026.
The most common disease conditions in clinical trials are Anxiety Disorders, Psychomotor Agitation, and Disease. The leading clinical trial sponsors are Azevan Pharmaceuticals, National Institute of Mental Health (NIMH), and National Institute of Neurological Disorders and Stroke (NINDS).
There are six US patents protecting this investigational drug and one hundred and four international patents.
Summary for SRX246
| US Patents | 6 |
| International Patents | 104 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2026-03-01) |
| Vendors | 26 |
Recent Clinical Trials for SRX246
| Title | Sponsor | Phase |
|---|---|---|
| Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome | Congressionally Directed Medical Research Programs | PHASE2 |
| Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome | Azevan Pharmaceuticals | PHASE2 |
| Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans | National Institute of Mental Health (NIMH) | Phase 1 |
Clinical Trial Summary for SRX246
Top disease conditions for SRX246
Top clinical trial sponsors for SRX246
US Patents for SRX246
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| SRX246 | ⤷ Start Trial | Use of arginine vasopressin receptor antagonists for the treatment of prostate cancer | UNIVERSITY OF MIAMI (Miami, FL) | ⤷ Start Trial |
| SRX246 | ⤷ Start Trial | Triazolobenzazepines as vasopressin V1a receptor antagonists | Richter Gedeon Nyrt | ⤷ Start Trial |
| SRX246 | ⤷ Start Trial | β-Lactamyl vasopressin V1a Antagonists | Azevan Pharmaceuticals Inc | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for SRX246
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| SRX246 | Australia | AU2002342045 | 2021-10-12 | ⤷ Start Trial |
| SRX246 | Bulgaria | BG108675 | 2021-10-10 | ⤷ Start Trial |
| SRX246 | Brazil | BR0213152 | 2021-10-10 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
